Skip to main content

Table 2 Pre-therapy and post-therapy on SRS in joints

From: Somatostatin receptor scintigraphy in patients with rheumatoid arthritis and secondary Sjögren’s syndrome treated with Infliximab: a pilot study

  Pre-therapy scan Post-therapy scan
Patient n Global score Severity index n Global score Severity index
1 13 23 1.8 6 8 1.3
3 5 5 1.0 4 4 1.0
4 2 2 1.0 2 2 1.0
5 1 3 3.0 1 1 1.0
6 7 13 1.9 3 4 1.3
7 10 15 1.5 6 7 1.2
8 4 8 2.0 3 4 1.3
9 4 14 3.5 2 5 2.5
12 10 20 2.0 7 13 1.9
14 12 22 1.8 5 6 1.2
18 8 14 1.8 2 3 1.5
Mean 6.9 12.6 1.9 3.7* 5.2** 1.4***
±SD 4.0 7.3 0.7 2.0 3.3 0.4
  1. The table shows values of the number of positive joints (n), of the global score and of the severity index in the joints of the 11 patients that performed somatostatin receptor scintigraphy (SRS) before and after treatment with Infliximab
  2. *p = 0.002 vs pre-therapy n; **p = 0.001 vs pre-therapy global score; ***p = 0.009 vs pre-therapy severity index